BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 23056490)

  • 1. Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemoresistant ovarian tumors.
    Latifi A; Luwor RB; Bilandzic M; Nazaretian S; Stenvers K; Pyman J; Zhu H; Thompson EW; Quinn MA; Findlay JK; Ahmed N
    PLoS One; 2012; 7(10):e46858. PubMed ID: 23056490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein markers of cancer-associated fibroblasts and tumor-initiating cells reveal subpopulations in freshly isolated ovarian cancer ascites.
    Wintzell M; Hjerpe E; Åvall Lundqvist E; Shoshan M
    BMC Cancer; 2012 Aug; 12():359. PubMed ID: 22901285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of stromal progenitor cells from ascites of patients with epithelial ovarian adenocarcinoma.
    Ho CM; Chang SF; Hsiao CC; Chien TY; Shih DT
    J Biomed Sci; 2012 Feb; 19(1):23. PubMed ID: 22330345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.
    Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY
    Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of ascites-derived ovarian tumor cells from spontaneously occurring ovarian tumors of the chicken: evidence for E-cadherin upregulation.
    Tiwari A; Hadley JA; Hendricks GL; Elkin RG; Cooper T; Ramachandran R
    PLoS One; 2013; 8(2):e57582. PubMed ID: 23460878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden.
    Abubaker K; Latifi A; Luwor R; Nazaretian S; Zhu H; Quinn MA; Thompson EW; Findlay JK; Ahmed N
    Mol Cancer; 2013 Mar; 12():24. PubMed ID: 23537295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGFβ signaling regulates epithelial-mesenchymal plasticity in ovarian cancer ascites-derived spheroids.
    Rafehi S; Ramos Valdes Y; Bertrand M; McGee J; Préfontaine M; Sugimoto A; DiMattia GE; Shepherd TG
    Endocr Relat Cancer; 2016 Mar; 23(3):147-59. PubMed ID: 26647384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characteristics and tumorigenicity of ascites-derived tumor cells: mitochondrial oxidative phosphorylation as a novel therapy target in ovarian cancer.
    Ding Y; Labitzky V; Legler K; Qi M; Schumacher U; Schmalfeldt B; Stürken C; Oliveira-Ferrer L
    Mol Oncol; 2021 Dec; 15(12):3578-3595. PubMed ID: 34060699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique proteome signature of post-chemotherapy ovarian cancer ascites-derived tumor cells.
    Ahmed N; Greening D; Samardzija C; Escalona RM; Chen M; Findlay JK; Kannourakis G
    Sci Rep; 2016 Jul; 6():30061. PubMed ID: 27470985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small Extracellular Vesicles Released from Ovarian Cancer Spheroids in Response to Cisplatin Promote the Pro-Tumorigenic Activity of Mesenchymal Stem Cells.
    Vera N; Acuña-Gallardo S; Grünenwald F; Caceres-Verschae A; Realini O; Acuña R; Lladser A; Illanes SE; Varas-Godoy M
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of mesothelial genes in ovarian carcinoma cells is associated with an unfavorable clinical outcome and the promotion of cancer cell adhesion.
    Ojasalu K; Brehm C; Hartung K; Nischak M; Finkernagel F; Rexin P; Nist A; Pavlakis E; Stiewe T; Jansen JM; Wagner U; Gattenlöhner S; Bräuninger A; Müller-Brüsselbach S; Reinartz S; Müller R
    Mol Oncol; 2020 Sep; 14(9):2142-2162. PubMed ID: 32533757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of cancer stem cells from high-grade serous ovarian carcinomas.
    He QZ; Luo XZ; Wang K; Zhou Q; Ao H; Yang Y; Li SX; Li Y; Zhu HT; Duan T
    Cell Physiol Biochem; 2014; 33(1):173-84. PubMed ID: 24504111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling of single circulating tumor cells in ovarian cancer - Establishment of a multi-marker gene panel.
    Blassl C; Kuhlmann JD; Webers A; Wimberger P; Fehm T; Neubauer H
    Mol Oncol; 2016 Aug; 10(7):1030-42. PubMed ID: 27157930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD166 promotes the cancer stem-like properties of primary epithelial ovarian cancer cells.
    Kim DK; Ham MH; Lee SY; Shin MJ; Kim YE; Song P; Suh DS; Kim JH
    BMB Rep; 2020 Dec; 53(12):622-627. PubMed ID: 32843129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microparticles from ovarian carcinomas are shed into ascites and promote cell migration.
    Press JZ; Reyes M; Pitteri SJ; Pennil C; Garcia R; Goff BA; Hanash SM; Swisher EM
    Int J Gynecol Cancer; 2012 May; 22(4):546-52. PubMed ID: 22315094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of spheroid cells from the HT29 colon cancer cell line.
    Fan X; Ouyang N; Teng H; Yao H
    Int J Colorectal Dis; 2011 Oct; 26(10):1279-85. PubMed ID: 21670985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells.
    Chiu WT; Huang YF; Tsai HY; Chen CC; Chang CH; Huang SC; Hsu KF; Chou CY
    Oncotarget; 2015 Feb; 6(4):2349-65. PubMed ID: 25537512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers.
    Lane D; Matte I; Garde-Granger P; Laplante C; Carignan A; Rancourt C; Piché A
    BMC Cancer; 2015 Jul; 15():492. PubMed ID: 26122176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-induced exosomes contribute to a more aggressive and chemoresistant ovarian cancer phenotype: a novel mechanism linking STAT3/Rab proteins.
    Dorayappan KDP; Wanner R; Wallbillich JJ; Saini U; Zingarelli R; Suarez AA; Cohn DE; Selvendiran K
    Oncogene; 2018 Jul; 37(28):3806-3821. PubMed ID: 29636548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Label-free microfluidic enrichment of cancer cells from non-cancer cells in ascites.
    Stone NE; Raj A; Young KM; DeLuca AP; Chrit FE; Tucker BA; Alexeev A; McDonald J; Benigno BB; Sulchek T
    Sci Rep; 2021 Sep; 11(1):18032. PubMed ID: 34504124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.